Citadel Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Buy
+34,782
New +$254K ﹤0.01% 10725
2025
Q4
Sell
-42,120
Closed -$455K 12614
2025
Q3
$776K Buy
42,120
+13,440
+47% +$216K ﹤0.01% 8096
2025
Q2
$373K Buy
28,680
+22,337
+352% +$264K ﹤0.01% 9312
2025
Q1
$67.2K Sell
6,343
-7,334
-54% -$116K ﹤0.01% 11974
2024
Q4
$232K Sell
13,677
-62,177
-82% -$1.17M ﹤0.01% 10170
2024
Q3
$1.76M Buy
75,854
+54,222
+251% +$1.16M ﹤0.01% 5777
2024
Q2
$527K Sell
21,632
-145,462
-87% -$4.41M ﹤0.01% 7941
2024
Q1
$5.64M Buy
167,094
+166,727
+45,430% +$5.91M 0.01% 3759
2023
Q4
$11.6K Sell
367
-147,506
-100% -$3.51M ﹤0.01% 13039
2023
Q3
$3.78M Buy
147,873
+25,962
+21% +$800K ﹤0.01% 4101
2023
Q2
$3.5M Sell
121,911
-192,878
-61% -$5.25M ﹤0.01% 4195
2023
Q1
$7.55M Buy
314,789
+11,483
+4% +$206K 0.01% 3177
2022
Q4
$5.14M Buy
303,306
+112,903
+59% +$1.97M 0.01% 3818
2022
Q3
$2.82M Buy
190,403
+126,867
+200% +$2.13M ﹤0.01% 4920
2022
Q2
$1M Sell
63,536
-34,097
-35% -$669K ﹤0.01% 7009
2022
Q1
$2.63M Buy
97,633
+82,316
+537% +$2.1M ﹤0.01% 5469
2021
Q4
$567K Sell
15,317
-56,420
-79% -$2.3M ﹤0.01% 9383
2021
Q3
$3.43M Buy
+71,737
New +$3.21M ﹤0.01% 5076
2021
Q2
Sell
-190,621
Closed -$6.45M 13621
2021
Q1
$7.87M Buy
190,621
+152,371
+398% +$9.08M 0.01% 3362
2020
Q4
$1.66M Sell
38,250
-271,999
-88% -$18.4M ﹤0.01% 5768
2020
Q3
$13.3M Sell
310,249
-388,035
-56% -$19.3M 0.02% 1966
2020
Q2
$32.6M Buy
698,284
+683,546
+4,638% +$23.6M 0.04% 1096
2020
Q1
$200K Buy
14,738
+1,805
+14% +$23.1K ﹤0.01% 8013
2019
Q4
$141K Buy
+12,933
New +$135K ﹤0.01% 8392
2017
Q2
Sell
-14,302
Closed -$114K 7442
2017
Q1
$114K Buy
+14,302
New +$132K ﹤0.01% 6808
2016
Q4
Sell
-2,085
Closed -$31.2K 7223
2016
Q3
$36K Buy
+2,085
New +$67.3K ﹤0.01% 6922
2016
Q1
Sell
-676
Closed -$22.9K 6715
2015
Q4
$30K Buy
+676
New +$30.4K ﹤0.01% 7667
2015
Q3
Sell
-149
Closed -$7K 8855
2015
Q2
$7K Sell
149
-1,946
-93% -$89.2K ﹤0.01% 8471
2015
Q1
$83K Buy
2,095
+1,244
+146% +$54.7K ﹤0.01% 6993
2014
Q4
$22K Buy
+851
New +$27.1K ﹤0.01% 7729

Other funds holding ARCT